Evidence map›Paper›PMID 40062810›Full record

Observational studyPediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies2025

Syndecan-1 as a Biomarker for Fluid Overload After High-Risk Pediatric Cardiac Surgery: A Pilot Study.

Matthew A Solomon, David S Hains, Andrew L Schwaderer, Katie Gallaway, Colin J Sallee, Francis Pike, Sam Arregui, Daniel T Cater, Christopher W Mastropietro, Courtney M Rowan

Abstract readObservational Study
In one paragraph

Observational study in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matthew A SolomonDivision of Pediatric Critical Care, Riley Hospital for Children, Indianapolis, IN.ORCID 0000-0002-9213-6487
David S HainsDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Andrew L SchwadererDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN.
Katie GallawayDivision of Pediatric Critical Care, Riley Hospital for Children, Indianapolis, IN.
Colin J SalleeDivision of Pediatric Critical Care Medicine, Department of Pediatrics, University of California Los Angeles, Los Angeles, CA.
Francis PikeDepartment of Biostatistics and Data Science, Indiana University, Indianapolis, IN.
Sam ArreguiDivision of Pediatric Nephrology, Riley Hospital for Children, Indianapolis, IN.
Daniel T CaterDivision of Pediatric Critical Care, Riley Hospital for Children, Indianapolis, IN.
Christopher W MastropietroDivision of Pediatric Critical Care, Riley Hospital for Children, Indianapolis, IN.
Courtney M RowanDivision of Pediatric Critical Care, Riley Hospital for Children, Indianapolis, IN.

Funding

Indiana University Kidney Training Program (IU-KTP)T32DK120524 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M · 2019 to 2023
$1.3M
Indiana Pediatric Scientist Award (IPSA)K12HD111057 · NICHD · INDIANA UNIVERSITY INDIANAPOLIS · PI David W Clapp, Carmella Evans-Molina · 2023 to 2026
$1.3M
Prognostic biomarkers for respiratory failure post hematopoietic cell transplantationK23HL150244 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI ROWAN, COURTNEY · 2020 to 2024
$899k
NHLBI NIH HHS K23 HL150244NICHD NIH HHS K12 HD111057NIDDK NIH HHS T32 DK120524
6 · The paper itself

Abstract

objectiveFluid overload (FO) after pediatric cardiac surgery with cardiopulmonary bypass (CPB) is common and has been associated with poor outcomes. We aimed to describe the relationship between plasma concentrations of syndecan-1 (SD1), a biomarker of endothelial glycocalyx injury, and FO in a cohort of children undergoing cardiac surgery.

designSingle-center prospective observational pilot study, 2022-2023.

settingTwenty-six-bed pediatric cardiac ICU (CICU) at a quaternary pediatric referral center. PATIENTS: Children younger than 18 years old undergoing Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery congenital heart surgery mortality category 3, 4, and 5 cardiac surgeries with CPB.

interventionsNone. MEASUREMENTS AND MAIN

resultsWe enrolled 15 patients. Blood samples were collected preoperatively and 4 hours postoperatively, then processed for plasma. SD1 concentrations were measured using enzyme-linked immunosorbent assays and compared with fluid balance on postoperative days (PODs) 1, 2, 3, and peak. SD1 discriminated fluid balance of greater than or equal to 10% on POD-1, POD-2, and POD-3 with an area under the receiver operating characteristic curve (AUROC) of 0.74, 0.84, and 0.88, respectively. SD1 also discriminated peak fluid balance of greater than or equal to 10% occurring on any day over the first seven PODs with an AUROC of 0.94. Patients with greater than or equal to 10% fluid balance on POD-2 ( p = 0.037), POD-3 ( p = 0.020), or peak ( p = 0.021) had significantly elevated delta SD1 when compared with those reaching less than 10%. Fluid balance of greater than or equal to 10% on POD-2 was associated with adverse events including longer duration of mechanical ventilation and CICU stay.

conclusionsPlasma SD1 was associated with FO in pediatric patients undergoing high-risk cardiac surgery with CPB. Further studies exploring the clinical utility of SD1 as a biomarker for FO in the postoperative management of children who undergo cardiac surgery with CPB should be pursued.

Indexed as

Cardiac Surgical ProceduresCardiopulmonary BypassPostoperative ComplicationsSyndecan-1Water-Electrolyte ImbalanceAdolescentBiomarkersChildChild, PreschoolFemaleHeart Defects, CongenitalHumansInfantInfant, NewbornIntensive Care Units, PediatricMaleBiomarkersSyndecan-1cardiac surgical procedurescardiopulmonary bypasscongenitalglycocalyxheart defectssyndecan-1

Identifiers

PMID40062810
PMCPMC12061566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.